CION Ameerpet
Pediatric Cancer — Parent FAQ
Is it safe to have another baby after child cancer?
Medically reviewed by Dr. Naresh Gundu, MD (Medical Oncology) · Last reviewed June 2026
When one child is diagnosed with cancer, one of the first questions many parents carry silently is: can we have more children? It is a question full of love, and also anxiety. For most families, the answer is reassuring — most childhood cancers are not inherited, and sibling cancer risk is low. This page explains when that is true, and when a conversation with a genetic counsellor makes sense first.
- Honest answers — a 45-minute consultation to discuss your family’s specific situation, not a generic leaflet
- Tumor board review — every child assessed by a multidisciplinary team, not a single doctor’s opinion
- Genetic counselling referral — if your child’s cancer warrants it, we coordinate the right specialist
- No rushed decisions — we walk this journey with you; your concerns are heard fully
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Understanding sibling cancer risk
Another baby after child cancer — what the science actually says
The fear is understandable. Your child has been diagnosed with cancer, and you want to protect every future child from the same experience. But fear without information is harder to carry than the truth — and the truth, for most families, is reassuring.
Most childhood cancers are not inherited. They arise from random errors that occur in a single cell as it divides during a child’s development. These errors are not present in the egg or sperm; they cannot be passed to a sibling. This is fundamentally different from some adult cancers, where a faulty gene can travel through families across generations. In paediatric oncology, the concept of “hereditary childhood cancer” exists — but it applies to a minority of cases, and there are usually identifiable features that suggest it.
The question of having more children — or how to protect a sibling already on the way — deserves an honest, personalised conversation with your child’s oncologist. Not a generic reassurance, but a review of the specific tumour type, any molecular testing that has been done, and your family history. That conversation takes 45 minutes. It can give you clarity that hours of internet searching cannot.
When your child’s cancer team does identify a hereditary element, that is not the end of the story — it is the beginning of a more informed plan. Modern genetic counselling, and in some situations preimplantation genetic testing during IVF, gives families real choices. The goal is never to frighten; it is to give you the information you need to make decisions that are right for your family.
Signs that suggest your child’s cancer may have a hereditary cause
If any of the following apply, a genetic counselling referral before another pregnancy is worth discussing with your oncology team.
Tumour type known to run in families
Bilateral retinoblastoma, pleuropulmonary blastoma, adrenocortical carcinoma in young children, and several others are strongly associated with hereditary changes.
Molecular testing found a germline variant
If your child’s molecular or genetic testing identified a pathogenic variant in normal (non-tumour) tissue, that change may be inherited and could be in your own genes too.
Your child developed two separate cancers
A child who develops two different primary cancers at different times is more likely to carry a hereditary predisposition that lowered the threshold for cancer to occur.
Family history of the same or related cancers
Multiple relatives with the same cancer, or a pattern of certain cancers across generations, may point to a shared hereditary change even if individual diagnoses appeared sporadic.
Very young age at diagnosis
Some cancer types that typically appear in adults occurring in a very young child can signal a hereditary predisposition syndrome that removed the usual protection.
Specific syndromes identified by clinical features
Conditions like neurofibromatosis, Beckwith–Wiedemann syndrome, or CMMRD may be diagnosed from clinical features, not just tumour testing, and carry defined cancer risks for siblings.
None of these features means cancer for a future child is certain — they mean the probability deserves to be calculated accurately, not guessed. A genetic counsellor translates these signals into personalised numbers you can actually plan around.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You deserve a clear answer — not more worry.
We walk this journey with you. A 45-minute consultation with no rushed decisions, and a written summary of what the team recommends for your family.
Having more kids after child cancer — a practical guide
Steps every parent should take before trying for another baby
Whether you are in active treatment, post-treatment follow-up, or years down the road — these steps give you and your partner the information you need to make this decision with confidence.
Ask your child’s oncologist directly about hereditary risk
Start with the team that knows your child’s diagnosis best. Ask specifically: “Is there anything about this cancer type that suggests a hereditary cause?” and “Has the tumour been tested for germline variants?” Many oncologists will raise this themselves — but asking directly puts it on the agenda if not. You deserve a clear answer, not a vague “it’s unlikely.”
Review what molecular or genetic testing has already been done
Many children with cancer have some form of molecular testing done on the tumour as part of diagnosis. It is worth asking whether that testing included germline (inherited) analysis, or only somatic (tumour-only) analysis. Tumour-only testing can miss inherited variants that are present in every cell of the body. If germline testing has not been done and the cancer type warrants it, asking for it now is a reasonable request.
Have a structured family history conversation
Draw out what you know about cancer diagnoses in both families — parents, grandparents, aunts, uncles, and cousins. Note the cancer types and the ages at diagnosis. Patterns matter: the same cancer appearing in several relatives, or cancers appearing at unusually young ages, are signals a genetic counsellor is trained to interpret. You do not need to be a doctor to do this — write down what you know and bring it to the consultation.
See a clinical geneticist or genetic counsellor if indicated
If Step 1 or Step 2 raises a concern, a referral to a clinical geneticist or genetic counsellor is the right next step. This specialist can review all available information, recommend specific germline testing for you and your partner if appropriate, and give you actual probability figures for a future child — not general reassurance. At CION, we can coordinate this referral as part of our paediatric oncology care pathway.
If a hereditary change is found — understand your options
Finding a hereditary change does not close the door on having more children. It opens a conversation about options. For couples who carry a known predisposing variant, preimplantation genetic testing (PGT) during IVF can identify embryos that did not inherit the change before implantation. Prenatal testing during a natural pregnancy is another option. Some families choose to continue without testing and instead focus on close surveillance for the new child after birth. A genetic counsellor will explain each path without pushing you toward any particular one — these are deeply personal decisions.
Plan the new sibling’s monitoring — before birth, not after
If a hereditary syndrome is confirmed, it is much easier to set up the new baby’s health surveillance plan before birth than to do so in a hurry after delivery. Ask your child’s oncologist and the genetic counsellor together: what regular check-ups should the new baby have, starting from when, and who should co-ordinate them? For most common hereditary syndromes in childhood cancer, published surveillance protocols exist — your care team can translate these into a practical calendar. Learn more about how childhood cancer is diagnosed to understand what early detection looks like in practice.
Take care of yourself through this process
The emotional weight of navigating a child’s cancer while asking questions about the future is significant. Genetic counsellors are trained to support the emotional as well as the informational side of these decisions. Our team at CION also works with psycho-oncologists who specialise in the family impact of a childhood cancer diagnosis. You do not have to carry this alone — and making a decision from a place of knowledge rather than fear is always better for you and for the family you are building.
Return to the Pediatric Cancer hub for a complete overview of paediatric cancer diagnosis, treatment, and support at CION Cancer Clinics across Hyderabad and Telangana.
15,000+ patients · 17 oncologists · 35+ centres
Families who walked this road with us found clarity — not just answers.
Our paediatric oncology team treats the whole family, not just the child. We walk this journey with you — from diagnosis through treatment and into your family’s future.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Your questions about having more children after a child has cancer — answered
Is it safe to have another baby after one of my children has been diagnosed with cancer?
For most families, yes — the vast majority of childhood cancers are not inherited and do not increase the risk for a sibling or future child in any meaningful way. Childhood cancers arise mostly from random mutations that occur as cells divide; they are not passed from parent to child through the genes in the way that, for example, some adult-onset conditions can be. That said, a small minority of childhood cancers — roughly 8–10% by current estimates in paediatric oncology literature — do occur in children who carry a predisposing genetic change. If your child’s cancer team has identified such a change, or if your family history suggests one, a formal genetic counselling assessment before another pregnancy is the right step. For families without this signal, the risk to a future sibling is low and a paediatric oncologist can give you a frank discussion of the specific numbers for your child’s diagnosis.
What is sibling cancer risk, and how do I find out if it applies to my family?
Sibling cancer risk is the probability that a brother or sister of a child with cancer will also develop cancer, above and beyond the general population risk. For most childhood cancers — including the common leukaemias, Wilms tumour in most cases, medulloblastoma in most cases, and many bone tumours — this additional sibling risk is very small. The risk is higher when the cancer is part of a recognised hereditary syndrome, such as Li–Fraumeni syndrome, familial retinoblastoma, DICER1 syndrome, or constitutional mismatch repair deficiency. Your child’s oncologist can review the tumour histology, molecular testing results, and family history together to decide whether genetic testing of your child — and possibly you and your partner — is recommended. A clinical geneticist or genetic counsellor is the right person to interpret results and give personal risk figures.
Should we have genetic testing before trying for another baby?
Genetic testing before another pregnancy is recommended when your child’s cancer has features that suggest a hereditary cause: a tumour type known to run in families (bilateral retinoblastoma, certain adrenocortical tumours, pleuropulmonary blastoma, etc.); molecular testing of the tumour showing a pathogenic variant that could be inherited; a family history of the same or related cancers in multiple relatives; or your child developing two separate primary cancers. In these situations, testing your child’s normal tissue (not just the tumour) and potentially testing you and your partner can clarify whether a hereditary change is present. If it is, a genetic counsellor can discuss the probability of passing it on and whether preimplantation genetic testing (PGT) during IVF is an option your family wants to consider. If none of these features are present, genetic testing before another pregnancy is not routinely needed.
If my child has leukaemia, does that mean the next baby could also get leukaemia?
Acute lymphoblastic leukaemia (ALL) — the most common childhood cancer — is very rarely hereditary in the classical sense. The vast majority of ALL cases arise from acquired mutations in bone marrow cells during a child’s lifetime; these mutations are not present in the egg or sperm and cannot be passed to siblings. A future sibling’s risk of developing ALL is not meaningfully higher than that of any other child in the general population. The one exception involves identical (monozygotic) twins: if one identical twin develops leukaemia in the first few years of life, the other twin has a significantly elevated risk, because a shared in-utero event may have seeded leukaemia cells in both. For non-identical twins or other siblings, the risk is reassuringly low. Your child’s haematologist-oncologist can confirm whether there are any features of your child’s specific leukaemia that warrant further genetic evaluation.
We are already pregnant. What should we tell the doctors about our older child's cancer?
Tell both your obstetrician and your child’s oncologist about the pregnancy as early as possible. Share the full details of your affected child’s diagnosis — including the exact tumour type and any genetic or molecular testing results that have been done. If a hereditary syndrome has been identified or suspected, your obstetrician may refer you to a maternal-fetal medicine specialist or a clinical geneticist for additional counselling. In most cases, no special monitoring of the pregnancy is needed. If a hereditary risk is confirmed, your team may discuss whether the new baby should have a specific health surveillance plan after birth — for example, abdominal ultrasounds every few months if a Wilms tumour predisposition syndrome is present. Early, open communication between all your doctors is the single most important step.
What monitoring should a new sibling have if our older child had cancer?
For most families, a new sibling does not need any cancer-specific monitoring beyond the standard child health checks every paediatrician performs. If your child’s cancer is linked to a hereditary syndrome, your genetic counsellor or oncologist will recommend a tailored surveillance plan for the new baby based on the specific syndrome. For example, children with a known TP53 change (Li–Fraumeni syndrome) may benefit from structured screening with whole-body MRI and blood tests at defined intervals. Children with a confirmed RB1 gene change linked to retinoblastoma need regular eye examinations from birth. These surveillance plans are designed by paediatric oncologists working with geneticists and are based on established guidelines — they are not guesswork. For families without a identified hereditary risk, the best advice is to remain alert to the warning signs of childhood cancer in any child and seek early evaluation if they appear.
Pediatric Cancer A–Z
Explore All Pediatric Cancer Topics
Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.